Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Rectal Neoplasms 5Uterine Cervical Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Glioblastoma 3Esophageal Neoplasms 3Breast Neoplasms 3Lung Neoplasms 2Carcinoma, Hepatocellular 2To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Pulmonary Fibrosis 1Prostatic Neoplasms 1Ototoxicity 1Neoplasms 1MSS Metastatic Colorectal Cancer 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Ketosis 1Insulin Resistance 1Hearing Loss 1Glioma 1Germinoma 1Esophageal Squamous Cell Carcinoma 1Cognitive Dysfunction 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1Acquired Immunodeficiency Syndrome 1

Interventions

dolutegravir 1Valganciclovir 1Ritonavir 1Radiotherapy 1Nucleosides 1Fluconazole 1Darunavir 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Acquired Immunodeficiency Syndrome × Radiotherapy × Clear all
NCT00122746 2011-10-13

Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

International Atomic Energy Agency

Phase 3 Unknown
322 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡